Institutional shares held 126 Million
605K calls
170K puts
Total value of holdings $1.69B
$8.09M calls
$2.28M puts
Market Cap $806M
60,187,500 Shares Out.
Institutional ownership 209.57%
# of Institutions 251


Latest Institutional Activity in ARQT

Top Purchases

Q2 2025
Gk Wealth Management LLC Shares Held: 18.8K ($252K)
Q1 2025
Paradigm Biocapital Advisors LP Shares Held: 1.47M ($19.6M)
Q1 2025
Nuveen, LLC Shares Held: 816K ($10.9M)
Q1 2025
Woodline Partners LP Shares Held: 410K ($5.49M)
Q1 2025
Vanguard Group Inc Shares Held: 6.82M ($91.3M)

Top Sells

Q2 2025
Silverleafe Capital Partners, LLC Shares Held: 14.5K ($194K)
Q1 2025
Millennium Management LLC Shares Held: 474K ($6.34M)
Q1 2025
Jennison Associates LLC Shares Held: 11.4M ($152M)
Q1 2025
Point72 Asset Management, L.P. Shares Held: 830K ($11.1M)
Q1 2025
Polar Capital Holdings PLC Shares Held: 6.71M ($89.8M)

About ARQT

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.


Insider Transactions at ARQT

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
567K Shares
From 21 Insiders
Grant, award, or other acquisition 475K shares
Open market or private purchase 32.2K shares
Bona fide gift 1.99K shares
Exercise of conversion of derivative security 58.4K shares
Sell / Disposition
500K Shares
From 8 Insiders
Bona fide gift 1.99K shares
Open market or private sale 498K shares

Track Institutional and Insider Activities on ARQT

Follow Arcutis Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

News

Receive news related to Arcutis Biotherapeutics, Inc.

Track Activities on ARQT